Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV).

Ital J Pediatr · 2015 · PMC4681171 · PMID 26670908

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

[ 70 ] demonstrated a decreasing trend of RSV infection hospitalizations in patients receiving prophylaxis with palivizumab, as was already shown by the Delphy study [ 71 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.